Advertisement
Home Tags Cancer: Leukemia

Tag: Cancer: Leukemia

American Society of Hematology, Dec. 5-8

The 57th American Society of Hematology Annual Meeting and Exposition The annual meeting of the American Society of Hematology was held from Dec....
Oral venetoclax and acalabrutinib are active in patients with relapsed or refractory chronic lymphocytic leukemia

ASH: Venetoclax, Acalabrutinib Active in Relapsed CLL

Two studies show beneficial effects for patients with relapsed chronic lymphocytic leukemia
For patients with previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma

ASH: Ibrutinib Bests Chlorambucil in Chronic Lymphocytic Leukemia

Improvements in progression-free survival, overall survival, response rate for ibrutinib
Researchers are zeroing in on factors that may increase the risk of leukemia after breast cancer treatment

Etiology of Leukemia in Breast Cancer Survivors Explored

Family history of cancer, inherited gene mutation seem to raise chances of secondary malignancy
Excess relative risk of computed tomography scans for quantification of cystic fibrosis can be calculated

Excess Relative Risk of Repeat CT Scans Can Be Quantified

Recent publication demonstrates that very low doses repeated over time as harmful as acute exposure
For children

Residential Pesticide Exposure May Raise Childhood Cancer Risk

Increased risk of childhood leukemia and lymphoma seen with indoor insecticide exposure
For patients with relapsed or refractory hairy-cell leukemia

Vemurafenib Deemed Highly Effective in Hairy-Cell Leukemia

Findings from two phase 2 studies in Italy and United States show short oral course is highly effective
An experimental therapy for chronic lymphocytic leukemia that uses a patient's own T cells (an approach known as CTL019) may cure some patients and prolong survival in others

Long-Term Remissions of CLL in First Personalized Cell Tx Trial

T cells reprogrammed to contain chimeric antigen receptor targeting CD19 protein on B cells
Patients with chronic myeloid leukemia who received a glitazone along with imatinib remained disease-free for up to nearly five years in a study published online Sept. 2 in Nature.

Addition of Glitazone to Chemo May Help Treat CML

Combining glitazones with standard treatment improved survival in small study
Older patients with acute myeloid leukemia are intense users of health care services and rarely use palliative care and hospice services

Older Cancer Patients Heavily Use Health Care Services

Regardless of chemo intensity, palliative care, hospice rarely used with acute myeloid leukemia